RE:RE:RE:The offering -- Sedar
Last one from Sedar:
UNDERTAKING
Ontario Securities Commission
British Columbia Securities Commission
Alberta Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
Re: Ventripoint Diagnostics Ltd. (the “Issuer”)
SEDAR Project No. 03282779
Final Short Form Prospectus dated October 13, 2021 under National
Instrument 44-101, Multilateral Instrument 11-102 and National Policy 11-
202
We refer to the Short Form Prospectus of Ventripoint Diagnostics Ltd. dated October 13, 2021
(the “Prospectus”) with respect to an offering of units of the Issuer.
The Issuer hereby undertakes, pursuant to subparagraph 4.2(a)(x) of National Instrument 44-101
Short Form Prospectus Distributions (“NI 44-101”), to file any agreement or contract referred to
in subparagraph 4.2(a)(iii) of NI 44-101 and any material contract under subparagraph
4.2(a)(iii.1) of NI 44-101 which has not been executed before the filing of the Prospectus, but will
be executed on or before the completion of the distribution of securities under the Prospectus,
promptly and in any event no later than seven days after the execution of the agreement, contract
or material contract.
The Issuer hereby undertakes, pursuant to subparagraph 4.2(a)(x.1) of NI 44-101, to file any
document referred to in subparagraph 4.2(a)(iii) of NI 44-101 which does not need to be executed
in order to become effective and has not become effective before the filing of the Prospectus but
will become effective on or before the completion of the distribution of securities under the
Prospectus, promptly and in any event no later than seven days after the document becomes
effective.
DATED this 13th day of October, 2021.
VENTRIPOINT DIAGNOSTICS LTD.
Per: “George Adams”
George Adams, CEO